Federal Supply Schedule 36F79719D0074
Award Date
2/1/19
Last Date to Order
3/1/26
Federal Agency
Veterans Integrated Service Network 12
Awardee
Alnylam Pharmaceuticals, Inc.
Ultimate Awardee
Not listed
NAICS Category
325412 - Pharmaceutical Preparation Manufacturing
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Fixed Price with Economic Price Adjustment
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Federal Supply Schedule (FSS) contract 36F79718D0514 was awarded by the Department of Veterans Affairs (VA) to Alkermes, Inc. for the provision of pharmaceutical and hematology-related products. This multiple-award contract falls under the GSA Schedule 61-IB for Pharmaceuticals and Drugs, with a period of performance extending to July 31, 2025 and a total ceiling value of $186,349,650.00. The contract aims to procure a wide range of pharmaceutical and hematology products to support the...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Exela Pharma Sciences LLC, is for the procurement of pharmaceuticals, drugs, and hematology-related products under FSS-61-IB. The contract has a ceiling value of $3,030,000.00 and a period of performance through September 28, 2024. As a multiple-award schedule contract, this FSS allows the VA and other eligible federal agencies to issue task orders for a wide range of pharmaceutical and drug...
The Federal Supply Schedule (FSS) contract awarded to Fera Pharmaceuticals, LLC is for the procurement of pharmaceutical drugs, pharmaceuticals, and hematology-related products. The prime contractor, Fera Pharmaceuticals, is a woman-owned small business that supplies the Department of Veterans Affairs (VA) and other government agencies with these products. The FSS contract, valued at up to $450,000.00, was awarded by the VA's Veterans Health Administration Veterans Integrated Service Network...
The Department of Veterans Affairs Veterans Health Administration Veterans Integrated Service Network 12 awarded a Federal Supply Schedule (FSS) contract to Genericus, Inc. under the Pharmaceuticals and Drugs (FSS-61-IB) FSS master schedule. The contract, valued at up to $225,000.00, enables the procurement of drugs, pharmaceuticals, and hematology-related products. As an FSS contract, this is a multiple award vehicle that allows for indefinite delivery of the specified products and services...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Axsome Therapeutics Inc., provides for the delivery of drugs, pharmaceuticals, and hematology-related products under Schedule 65 I B. The $25,000 contract has a period of performance through February 28, 2023. As a multiple award FSS, this contract allows for orders to be placed by any federal agency. The contract does not utilize any set-asides. This interim agreement under the FSS facilitates the...
This Federal Supply Schedule (FSS) contract was awarded by the Department of Veterans Affairs (VA) to NS Pharma, Inc., a foreign-owned for-profit manufacturer of pharmaceutical and hematology-related products. The contract, with a ceiling value of $225,000, has an ultimate completion date of March 14, 2026 and was originally awarded on March 15, 2021. The scope of the contract includes the provision of "Drugs, Pharmaceuticals, & Hematology Related Products" under the GSA Schedule...
This is a Federal Supply Schedule (FSS) contract awarded by the Department of Veterans Affairs (VA) to Enzyvant Therapeutics Inc. The contract is for pharmaceutical and hematology-related products under Schedule 65 I B of the FSS program. The contract has a ceiling value of $25,000.00 and a period of performance from January 1, 2023 to June 30, 2023. As an FSS contract, this is a multiple award vehicle allowing other federal agencies to place orders against the schedule. The contract was awarded...
This Federal Supply Schedule (FSS) contract, awarded by the Department of Veterans Affairs (VA) to Ingenus Pharmaceuticals, LLC, provides for the procurement of pharmaceutical and hematology-related products. The $5.2 million, multiple-award contract has a performance period extending through December 14, 2025. As a Federal Supply Schedule contract under the Pharmaceuticals and Drugs (FSS-61-IB) program, this agreement allows the VA and other federal agencies to order a variety of pharmaceutical...
This Federal Supply Schedule (FSS) contract was awarded by the Veterans Integrated Service Network 12, a civilian federal agency, to GC Biopharma USA, Inc. The contract has a ceiling value of $25,000.00 and a period of performance through January 14, 2025. The FSS contract is for the procurement of drugs, pharmaceuticals, and hematology related products under Schedule 65 IB. Additionally, a Blanket Purchase Agreement (BPA) was awarded under this FSS contract with a ceiling value of...
This Federal Supply Schedule (FSS) contract, awarded by the Veterans Integrated Service Network 12 (VISN 12) of the U.S. Department of Veterans Affairs, is for the procurement of pharmaceuticals, drugs, and hematology-related products. The contract was awarded to Haleon US LP, a for-profit manufacturer, with a ceiling value of $9,867,650.00 and a period of performance through September 30, 2026. The FSS contract, categorized under Schedule 65 IB, aims to provide the VA's VISN 12 with a wide...